Pollescas, Kenth Ivan .

HRN: 22-11-43  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
10/25/2022
11/01/2022
PO
3 Ml
Q12
T/C PSGN
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: